Literature DB >> 35098329

Pain catastrophizing in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: biopsychosocial perspective and impact on health-related quality of life.

Mateusz Wilk1, Katarzyna Łosińska2, Are H Pripp3, Mariusz Korkosz2,4, Glenn Haugeberg5,6.   

Abstract

Pain catastrophizing (PC), defined as tendency to describe pain in more exaggerated terms, to ruminate more or to feel helpless about it. Main objective was to illuminate PC in rheumatoid arthritis (RA), psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA), revealing its prevalence and associations from a biopsychosocial perspective, including its association with health-related quality of life (HRQoL). Measures reflecting the biological, social and psychological perspective were recorded in RA, PsA and axSpA outpatients. Biological variables including demographics, disease activity and patient reported outcomes (PROs) along with variables reflecting psychological and social domains were collected. RAND12 questionnaire was used to explore HRQoL and standardized questionnaire was used to reveal pain catastrophizing score (PCS). 1229 patients were recruited (RA 580, PsA 394, axSpA 255). Mean (SD) PCS were for RA 1.88 (1.39), PsA 2.06 (1.45) and axSpA 2.27 (1.37). Proportion of pain catastrophizers (score ≥ 4) was not statistically different between RA (10.5%), PsA (12.7%) and axSpA (15.3%). Across all diagnoses, variables reflecting biological subjective domain explained more PCS variability (adjusted R2 35.3-49.9%) than psychological (28.4-33.6%), social (22.4-28.4%) and biological objective (4.3-9.9%) domains. HRQoL was significantly lower in pain catastrophizers across all diagnoses. No substantial differences in proportion of pain catastrophizers between RA, PsA and axSpA patients were found. Higher PCS (score ≥ 4) was best explained by biological subjective measures and corresponded with inferior HRQoL in all diseases. Several biological objectives, psychological and social measures were also associated with higher PCS.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Inflammatory diseases; Pain; Pain catastrophizing; Quality of life

Mesh:

Year:  2022        PMID: 35098329     DOI: 10.1007/s00296-021-05070-4

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  33 in total

1.  Do depression and anxiety reduce the likelihood of remission in rheumatoid arthritis and psoriatic arthritis? Data from the prospective multicentre NOR-DMARD study.

Authors:  Brigitte Michelsen; Eirik Klami Kristianslund; Joseph Sexton; Hilde Berner Hammer; Karen Minde Fagerli; Elisabeth Lie; Ada Wierød; Synøve Kalstad; Erik Rødevand; Frode Krøll; Glenn Haugeberg; Tore K Kvien
Journal:  Ann Rheum Dis       Date:  2017-07-21       Impact factor: 19.103

2.  Discordance between tender and swollen joint count as well as patient's and evaluator's global assessment may reduce likelihood of remission in patients with rheumatoid arthritis and psoriatic arthritis: data from the prospective multicentre NOR-DMARD study.

Authors:  Brigitte Michelsen; Eirik Klami Kristianslund; Hilde Berner Hammer; Karen Minde Fagerli; Elisabeth Lie; Ada Wierød; Synøve Kalstad; Erik Rødevand; Frode Krøll; Glenn Haugeberg; Tore K Kvien
Journal:  Ann Rheum Dis       Date:  2016-10-04       Impact factor: 19.103

3.  Health-related quality of life in patients with psoriatic and rheumatoid arthritis: data from the prospective multicentre NOR-DMARD study compared with Norwegian general population controls.

Authors:  Brigitte Michelsen; Till Uhlig; Joseph Sexton; Désirée van der Heijde; Hilde Berner Hammer; Eirik Klami Kristianslund; Ada Wierød; Gunnstein Bakland; Erik Rødevand; Frode Krøll; Jon Håvard Loge; Glenn Haugeberg; Tore K Kvien
Journal:  Ann Rheum Dis       Date:  2018-06-06       Impact factor: 19.103

4.  Preferences for improved health examined in 1,024 patients with rheumatoid arthritis: pain has highest priority.

Authors:  Turid Heiberg; Tore K Kvien
Journal:  Arthritis Rheum       Date:  2002-08

5.  Comparison of health-related quality of life in rheumatoid arthritis, psoriatic arthritis and psoriasis and effects of etanercept treatment.

Authors:  Vibeke Strand; Veronika Sharp; Andrew S Koenig; Grace Park; Yifei Shi; Brian Wang; Debra J Zack; David Fiorentino
Journal:  Ann Rheum Dis       Date:  2012-01-17       Impact factor: 19.103

6.  The impact of different rheumatic diseases on health-related quality of life: a comparison with a selected sample of healthy individuals using SF-36 questionnaire, EQ-5D and SF-6D utility values.

Authors:  Fausto Salaffi; Marco Di Carlo; Marina Carotti; Sonia Farah; Alessandro Ciapetti; Marwin Gutierrez
Journal:  Acta Biomed       Date:  2019-01-15

7.  The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy people.

Authors:  Fausto Salaffi; Marina Carotti; Stefania Gasparini; Michele Intorcia; Walter Grassi
Journal:  Health Qual Life Outcomes       Date:  2009-03-18       Impact factor: 3.186

8.  The relationship between demographic- and disease-related variables and health-related quality of life in patients with axial spondyloarthritis.

Authors:  Gudrun Rohde; Kari Hansen Berg; Anne Prøven; Glenn Haugeberg
Journal:  BMC Musculoskelet Disord       Date:  2017-08-01       Impact factor: 2.362

9.  International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials.

Authors:  Ana-Maria Orbai; Maarten de Wit; Philip Mease; Judy A Shea; Laure Gossec; Ying Ying Leung; William Tillett; Musaab Elmamoun; Kristina Callis Duffin; Willemina Campbell; Robin Christensen; Laura Coates; Emma Dures; Lihi Eder; Oliver FitzGerald; Dafna Gladman; Niti Goel; Suzanne Dolwick Grieb; Sarah Hewlett; Pil Hoejgaard; Umut Kalyoncu; Chris Lindsay; Neil McHugh; Bev Shea; Ingrid Steinkoenig; Vibeke Strand; Alexis Ogdie
Journal:  Ann Rheum Dis       Date:  2016-09-09       Impact factor: 19.103

10.  Comparative Disease Burden in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, or Axial Spondyloarthritis: Data from Two Corrona Registries.

Authors:  Philip J Mease; Mei Liu; Sabrina Rebello; Hyungjoo Kang; Esther Yi; Yujin Park; Jeffrey D Greenberg
Journal:  Rheumatol Ther       Date:  2019-09-16
View more
  1 in total

1.  The reliability, validity, and responsiveness of Cognitive Exercise Therapy Approach: Biopsychosocial Questionnaire for patients with psoriatic arthritis.

Authors:  Senem Bulut; Jale Karakaya; Sevim Oksuz; Umut Kalyoncu; Edibe Unal
Journal:  Rheumatol Int       Date:  2022-07-13       Impact factor: 3.580

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.